Enhanced Risk Profiling of Implanted Defibrillator Shocks with Circulating SCN5A MRNA Splicing Variants: a Pilot Trial

Overview

Journal J Am Coll Cardiol

Specialty Cardiology & Vascular Diseases

Date 2014 Apr 8

PMID 24703920

Citations 11

Authors

Ge Gao

Vikram Brahmanandam

Mihai Raicu

Lianzhi Gu

Li Zhou

Srinivasan Kasturirangan

Anish Shah

Smita I Negi

Melissa R Wood

Ankit A Desai

Antone Tatooles

Alan Schwartz

Samuel C Dudley Jr

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study was to determine the association of SCN5A cardiac sodium (Na(+)) channel mRNA splice variants in white blood cells (WBCs) with risk of arrhythmias in heart failure (HF).

Background: HF is associated with upregulation of two cardiac SCN5A mRNA splice variants that encode prematurely truncated, nonfunctional Na(+) channels. Because circulating WBCs demonstrate similar SCN5A splicing patterns, we hypothesized that these WBC-derived splice variants might further stratify patients with HF who are at risk for arrhythmias.

Methods: Simultaneously obtained myocardial core samples and WBCs were compared for SCN5A variants C (VC) and D (VD). Circulating variant levels were compared among patients with HF, divided into three groups: HF without an implantable cardioverter-defibrillator (ICD), HF with an ICD without appropriate intervention, and HF with an ICD with appropriate intervention.

Results: Myocardial tissue-derived SCN5A variant expression levels strongly correlated with circulating WBC samples for both VC and VD variants (r = 0.78 and 0.75, respectively). After controlling for covariates, patients with HF who had received an appropriate ICD intervention had higher expression levels of both WBC-derived SCN5A variants compared with patients with HF with ICDs who had not received appropriate ICD intervention (odds ratio, 3.25; 95% CI, 1.64-6.45; p = 0.001). Receiver operating characteristic analysis revealed that circulating SCN5A variant levels were highly associated with the risk for appropriate ICD intervention (area under the curve ≥0.97).

Conclusions: Circulating expression levels of SCN5A variants were strongly associated with myocardial tissue levels. Furthermore, circulating variant levels were correlative with arrhythmic risk as measured by ICD events in an HF population within 1 year. (Sodium Channel Splicing in Heart Failure Trial [SOCS-HEFT]; NCT01185587).

Citing Articles

Cardiac splicing as a diagnostic and therapeutic target.

Gotthardt M, Badillo-Lisakowski V, Parikh V, Ashley E, Furtado M, Carmo-Fonseca M Nat Rev Cardiol. 2023; 20(8):517-530.

PMID: 36653465 DOI: 10.1038/s41569-022-00828-0.

Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine-Mediated Inhibition of Connexin43 Expression.

Lazzerini P, Acampa M, Cupelli M, Gamberucci A, Srivastava U, Nanni C J Am Heart Assoc. 2021; 10(21):e022095.

PMID: 34713715 PMC: 8751850. DOI: 10.1161/JAHA.121.022095.

Cardiac Resynchronization and Circulating Markers of Sarcoplasmic Reticulum Calcium Handling and Sudden Death Risk.

Jiang N, Zhou A, Imran H, Shi G, Kaseer B, Siu V JACC Clin Electrophysiol. 2021; 7(9):1079-1083.

PMID: 34454876 PMC: 8463435. DOI: 10.1016/j.jacep.2021.07.003.

MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel.

Kang G, Xie A, Liu H, Dudley Jr S JCI Insight. 2020; 5(23).

PMID: 33108349 PMC: 7714400. DOI: 10.1172/jci.insight.140759.

Alternative Splicing of the Cardiac Sodium Channel in Pulmonary Arterial Hypertension.

Banerjee D, Grammatopoulos T, Palmisciano A, Klinger J, Krishnan I, Whittenhall M Chest. 2020; 158(2):735-738.

PMID: 32112775 PMC: 7417372. DOI: 10.1016/j.chest.2019.12.052.

References

Huikuri H, Makikallio T, Raatikainen M, Perkiomaki J, Castellanos A, Myerburg R . Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation. 2003; 108(1):110-5. DOI: 10.1161/01.CIR.0000077519.18416.43. View

Verma A, Sarak B, Kaplan A, Oosthuizen R, Beardsall M, Wulffhart Z . Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2009; 33(3):320-9. DOI: 10.1111/j.1540-8159.2009.02566.x. View

Buxton A, Ellison K, Lorvidhaya P, Ziv O . Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation. J Cardiovasc Pharmacol. 2010; 55(5):450-5. View

Roger V, Go A, Lloyd-Jones D, Benjamin E, Berry J, Borden W . Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2011; 125(1):e2-e220. PMC: 4440543. DOI: 10.1161/CIR.0b013e31823ac046. View

Gao G, Xie A, Zhang J, Herman A, Jeong E, Gu L . Unfolded protein response regulates cardiac sodium current in systolic human heart failure. Circ Arrhythm Electrophysiol. 2013; 6(5):1018-24. PMC: 3909518. DOI: 10.1161/CIRCEP.113.000274. View

Kanter R, Pfeiffer R, Hu D, Barajas-Martinez H, Carboni M, Antzelevitch C . Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay. Circulation. 2011; 125(1):14-22. PMC: 3519939. DOI: 10.1161/CIRCULATIONAHA.111.054007. View

Saba S . Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria. Heart Fail Clin. 2011; 7(2):175-83, vii. DOI: 10.1016/j.hfc.2010.12.004. View

Bailey J, Berson A, HANDELSMAN H, Hodges M . Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol. 2001; 38(7):1902-11. DOI: 10.1016/s0735-1097(01)01667-9. View

Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View

10.

Allen LaPointe N, Al-Khatib S, Piccini J, Atwater B, Honeycutt E, Thomas K . Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. Circ Cardiovasc Qual Outcomes. 2011; 4(2):146-51. DOI: 10.1161/CIRCOUTCOMES.110.958603. View

11.

Costantini O, Hohnloser S, Kirk M, Lerman B, Baker 2nd J, Sethuraman B . The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol. 2009; 53(6):471-9. DOI: 10.1016/j.jacc.2008.08.077. View

12.

Royer A, van Veen T, Le Bouter S, Marionneau C, Griol-Charhbili V, Leoni A . Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation. 2005; 111(14):1738-46. DOI: 10.1161/01.CIR.0000160853.19867.61. View

13.

Buxton A, Lee K, Hafley G, Pires L, Fisher J, Gold M . Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007; 50(12):1150-7. DOI: 10.1016/j.jacc.2007.04.095. View

14.

Sotoodehnia N, Isaacs A, de Bakker P, Dorr M, Newton-Cheh C, Nolte I . Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010; 42(12):1068-76. PMC: 3338195. DOI: 10.1038/ng.716. View

15.

Shang L, Pfahnl A, Sanyal S, Jiao Z, Allen J, Banach K . Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ Res. 2007; 101(11):1146-54. PMC: 3157752. DOI: 10.1161/CIRCRESAHA.107.152918. View

16.

Pan Q, Shai O, Lee L, Frey B, Blencowe B . Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008; 40(12):1413-5. DOI: 10.1038/ng.259. View

17.

Ferreira Santos L, Rodrigues B, Moreira D, Correia E, Nunes L, Costa A . Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome. Europace. 2012; 14(6):882-8. DOI: 10.1093/europace/eur421. View

18.

Zhou A, Ou A, Cho A, Benz Jr E, Huang S . Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection. Mol Cell Biol. 2008; 28(19):5924-36. PMC: 2546994. DOI: 10.1128/MCB.00560-08. View

19.

Winkel B, Larsen M, Berge K, Leren T, Nissen P, Olesen M . The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases. J Cardiovasc Electrophysiol. 2012; 23(10):1092-8. DOI: 10.1111/j.1540-8167.2012.02371.x. View

20.

Remme C, Bezzina C . Sodium channel (dys)function and cardiac arrhythmias. Cardiovasc Ther. 2010; 28(5):287-94. DOI: 10.1111/j.1755-5922.2010.00210.x. View